Sun P, Li Y, Li C, Ren K, et al. A Phase II Study of Sintilimab, Anlotinib, and Pegaspargase Sandwiched with Radiotherapy as First-line Therapy in Patients with Newly Diagnosed, Stage I-II Extranodal Natural-killer/T-cell Lymphoma. Am J Hematol 2023 Mar 27. doi: 10.1002/ajh.26922.
PMID: 36970971